NCT00128778 2023-03-06
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Spanish Breast Cancer Research Group
Phase 4 Completed
Clinical Trials
8 trialsNCT03794778 2022-07-18
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 4 Unknown
NCT05302336 2022-04-14
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT03892330 2019-03-27
Combination Therapy of Anthracyclines for Children With Nephroblastoma
Shengjing Hospital
Phase 4 Not yet recruiting
NCT00727961 2017-06-08
A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00604968 2017-06-07
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00779285 2015-07-14
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00531973 2009-02-18
LITE
Catholic University, Italy
Phase 4 Unknown